Cabometyx 60 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKK0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,757
Award facts
- Contract value 100% obligated
- $35,757.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,757.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cabometyx 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The order will be fulfilled from the vendor's Park Ridge facility and represents one of numerous pharmaceutical supply orders DMS Pharmaceutical Group has received from the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for the Department of Defense. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. As a prime vendor contractor under this program, DMS Pharmaceutical Group supplies critical oncology treatments, immunosuppressants, vaccines, and other specialized pharmaceuticals essential to Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FKKK0?
SPE2DR26FKKK0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FKKK0 worth?
The government has obligated $35,757 on SPE2DR26FKKK0.
Is contract SPE2DR26FKKK0 an order under another contract?
Yes. SPE2DR26FKKK0 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKK0 competed?
The extent of competition for SPE2DR26FKKK0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award